Lido Advisors, LLC Vericel Corp Transaction History

Lido Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 17, 2022	SELL	$31.69 - $43.29 $271,298 - $370,605	-8,561 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$35.2 - $52.6 $126,473 - $188,991	3,593 Added 72.32%	8,561 $336,000
Q3 2021 Feb 15, 2022	BUY	$46.35 - $59.75 $15,712 - $20,255	339 Added 7.32%	4,968 $242,000
Q3 2021 Nov 12, 2021	BUY	$46.35 - $59.75 $214,554 - $276,582	4,629 New	4,629 $242,000

279

48.7M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.76B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Lido Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Lido Advisors, LLC with notifications on news.